Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573646 | SCV000669101 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001082604 | SCV000760559 | likely benign | Familial melanoma | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759741 | SCV000889271 | benign | not provided | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000759741 | SCV001916882 | benign | not provided | 2015-05-19 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004787936 | SCV005405341 | benign | Melanoma, cutaneous malignant, susceptibility to, 3 | 2024-09-26 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004745485 | SCV005366407 | likely benign | CDK4-related disorder | 2024-09-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |